Table: Brightpath Biotherapeutics - Q1 parent results

BrightPath Biotherapeutics Co

09/08/2024 07:07

Aug 9 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2024        Jun 30, 2023      Mar 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             0 mln     
                 (+66.7 pct)         (-84.2 pct)       (-31.3 pct)  
  Operating     loss 326 mln        loss 293 mln      loss 925 mln  
  Recurring     loss 329 mln        loss 293 mln      loss 925 mln  
  Net           loss 330 mln        loss 295 mln      loss 927 mln  
  EPS           loss 4.66 yen       loss 4.70 yen    loss 13.08 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T